Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HODGKIN LYMPHOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00290511
What this trial is testing

Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 49
Large-scale testing (Phase 3)Study completedNCT00146211
What this trial is testing

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

Who this might be right for
Huntington Disease
Amarin Neuroscience Ltd 300
Testing effectiveness (Phase 2)Ended earlyNCT02091063
What this trial is testing

ACY-1215 for Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
LymphomaLymphoid Malignancies
Jennifer Amengual 23
Testing effectiveness (Phase 2)WithdrawnNCT04882163
What this trial is testing

Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Celgene
Not applicableStudy completedNCT00002563
What this trial is testing

SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease

Who this might be right for
LymphomaPsychosocial Effects of Cancer and Its Treatment
SWOG Cancer Research Network 263
Not applicableUnknownNCT03672084
What this trial is testing

Allo-HSCT as First-line Consolidation in High-risk PTCL

Who this might be right for
T Cell Lymphoma
Peking University People's Hospital 50
Large-scale testing (Phase 3)Study completedNCT03357471
What this trial is testing

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more
UCB Biopharma S.P.R.L. 70
Not applicableStudy completedNCT02296398
What this trial is testing

Long-term Use of Romidepsin in Patients With CTCL

Who this might be right for
Cutaneous T-cell Lymphoma
Northwestern University 47
Large-scale testing (Phase 3)Active Not RecruitingNCT04224493
What this trial is testing

Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

Who this might be right for
Relapsed/Refractory Follicular LymphomaFollicular LymphomaRefractory Follicular Lymphoma
Epizyme, Inc. 599
Testing effectiveness (Phase 2)UnknownNCT04723914
What this trial is testing

Dual Target CAR-T Cells in B-cell Lymphoma

Who this might be right for
Lymphoma, B-CellRelapse/RecurrenceRefractory Lymphoma+1 more
YuLi 20
Testing effectiveness (Phase 2)UnknownNCT04850664
What this trial is testing

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

Who this might be right for
Opioid Use Disorder, ModerateOpioid Use Disorder, SevereWithdrawal Symptoms+2 more
Evon Medics LLC 190
Early research (Phase 1)Ended earlyNCT00054834
What this trial is testing

Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Gilead Sciences 27
Testing effectiveness (Phase 2)Study completedNCT01980654
What this trial is testing

Study of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma

Who this might be right for
Follicular LymphomaB-cell LymphomaNon-Hodgkin's Lymphoma
Pharmacyclics LLC. 80
Very early researchActive Not RecruitingNCT07585851
What this trial is testing

Administration of Repurposed Ketoconazole in Glioma Patients

Who this might be right for
Diffuse GliomaDiffuse Glioma, Grade IDiffuse Glioma, Grade II+2 more
Universitas Padjadjaran 80
Not applicableActive Not RecruitingNCT04567394
What this trial is testing

Cannabis Use Disorder Treatment Study

Who this might be right for
Cannabis Use Disorder, MildCannabis Use Disorder, ModerateCannabis Use Disorder, Severe
The University of Tennessee, Knoxville 1,077
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Large-scale testing (Phase 3)Study completedNCT01686594
What this trial is testing

PUVA Maintenance Therapy in Mycosis Fungoides

Who this might be right for
Patch/Plaque Stage Mycosis Fungoides
Medical University of Graz 28
Early research (Phase 1)Looking for participantsNCT06815029
What this trial is testing

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma
City of Hope Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT00535470
What this trial is testing

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
Yaupon Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT00609869
What this trial is testing

Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab

Who this might be right for
Lymphocytic LeukemiaMantle Cell Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 29
Next Page